Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSIGHT: Yesafili vs Eylea in Diabetic Macular Edema
NCT03610646Phase 3Completed
- Sponsor
- Mylan
- Start
- Aug 2018
- Primary completion
- Nov 2020
- Modality
- Fc-Fusion Proteins
- Countries
- 9
01
Overview
A Phase 3 trial of M710 in diabetic macular edema (DME), sponsored by Mylan. Started Aug 2018; status: completed.
02
Drugs
M710
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT03610646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03610646.